BIOLIFE SOLUTIONS INC 8-K SEC Filings

Filed On	Filing
06 Oct 2026	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing +5 more 1.1 Registered Office. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware.
09 Sep 2026	8-K: Other Events As previously disclosed, on July 21, 2026, BioLife Solutions, Inc., a Delaware corporation (“BioLife”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Repligen Corporation, a Delaware corporation (“Repligen”),...
06 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	8-K: Regulation FD Disclosure
22 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
03 Jun 2026	8-K: Regulation FD Disclosure
07 May 2026	8-K: Results of Operations and Financial Condition
02 Mar 2026	8-K: Regulation FD Disclosure
26 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Results of Operations and Financial Condition
09 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Nov 2025	8-K: Regulation FD Disclosure
06 Nov 2025	8-K: Results of Operations and Financial Condition
21 Aug 2025	8-K: Submission of Matters to a Vote of Security Holders
07 Aug 2025	8-K: Results of Operations and Financial Condition
08 May 2025	8-K: Results of Operations and Financial Condition
24 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation
03 Mar 2025	8-K: Financial Statements and Exhibits
13 Jan 2025	8-K: Financial Statements and Exhibits
20 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments